Noxopharm Ltd (NOX) — Financial Flexibility Index
Noxopharm Ltd (NOX) has a Financial Flexibility Index of -0.46x as of December 2025. Free cash flow of AU$-2.71 Million (operating CF AU$-2.71 Million minus capex AU$0.00) represents 0% of total liabilities (AU$5.88 Million). Check NOX cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Noxopharm Ltd Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Noxopharm Ltd across 10 annual periods. For the full cash flow conversion analysis, see Noxopharm Ltd (NOX) cash conversion ratio.
Annual Financial Flexibility Index for Noxopharm Ltd (2016–2025)
Year-by-year free cash flow to debt coverage for Noxopharm Ltd. Explore how well can Noxopharm Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.50x | AU$-5.82 Million | AU$-5.82 Million | AU$3.89 Million | ▼ -181.9% |
| 2024 | -0.53x | AU$-684.31K | AU$-684.31K | AU$1.29 Million | ▲ +94.9% |
| 2023 | -10.37x | AU$-10.95 Million | AU$-10.95 Million | AU$1.06 Million | ▼ -87.0% |
| 2022 | -5.55x | AU$-13.73 Million | AU$-13.73 Million | AU$2.48 Million | ▼ -343.6% |
| 2021 | -1.25x | AU$-8.85 Million | AU$-8.85 Million | AU$7.08 Million | ▲ +19.2% |
| 2020 | -1.55x | AU$-11.13 Million | AU$-11.14 Million | AU$7.19 Million | ▲ +8.9% |
| 2019 | -1.70x | AU$-9.77 Million | AU$-9.78 Million | AU$5.75 Million | ▲ +14.7% |
| 2018 | -1.99x | AU$-8.76 Million | AU$-9.08 Million | AU$4.40 Million | ▲ +74.7% |
| 2017 | -7.86x | AU$-2.84 Million | AU$-2.92 Million | AU$361.04K | ▼ -288.5% |
| 2016 | -2.02x | AU$-529.79K | AU$-549.72K | AU$261.72K | — |